Five9 vs IBEX
FIVN and IBEX side by side, both in computer programming, data processing, and other computer related services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How FIVN and IBEX compare
Five9 is the larger company, worth 2.7 times as much as IBEX ($2.0B against $756M).
On earnings, IBEX is cheaper: it trades at 17.2× trailing earnings, against 40.8× for Five9.
IBEX grew revenue faster over the last twelve months (15.2% versus 10.1% for Five9).
IBEX keeps more of each dollar of sales as profit, with a net margin of 7.3% compared with 4.5% at Five9.
IBEX scores higher on the StockData Score (17 against 10 for Five9), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | FIVN | IBEX |
|---|---|---|
| Size and price | ||
| Market cap | $2.0B | $756M |
| Share price | $27.32 | $56.92 |
| Change, 1 year | 30.2% | 54.7% |
| Change, 5 years | −81.8% | 221% |
| Beta (5Y) | 1.96 | 0.73 |
| Employees | 2,910 | 35K |
| StockData Score | ||
| Total score | 10 | 17 (better) |
| Valuation score | 2 | 2 |
| Growth score | 3 | 3 |
| Performance score | 4 | 6 (better) |
| Health score | 1 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 40.8× | 17.2× (better) |
| P/S | 1.6× | 1.1× (better) |
| P/B | 2.4× (better) | 4.2× |
| EV/EBITDA | 10.4× | 9.0× (better) |
| P/FCF | 9.6× (better) | 23.4× |
| PEG | – | 0.74 |
| FCF yield | 10.5% (better) | 4.3% |
| Fair value | $29.43 | $60.76 |
| Margin of safety | 7.2% (better) | 6.3% |
| Growth | ||
| Revenue growth (TTM) | 10.1% | 15.2% (better) |
| Revenue growth, 5Y average | 21.4% (better) | 7.8% |
| Net income growth (TTM) | 79.0% (better) | 18.6% |
| EPS growth (TTM) | 86.1% (better) | 18.7% |
| EPS growth, 5Y average | – | 34.5% |
| Profitability | ||
| Gross margin | 54.5% (better) | 29.4% |
| Operating margin | 4.4% | 8.9% (better) |
| Net margin | 4.5% | 7.3% (better) |
| FCF margin | 17.2% (better) | 4.8% |
| Return on equity | 6.9% | 30.2% (better) |
| Return on invested capital | 40.1% (better) | 36.8% |
| Financial health | ||
| Debt / equity | – | 0.01 |
| Net debt / EBITDA | – | −0.44 |
| Interest coverage | 4.1× | 64.9× (better) |
| Current ratio | 4.00 (better) | 2.03 |
| Altman Z-score | 2.11 | 6.33 (better) |
| Piotroski F-score | 7 | 8 (better) |
| Dividends and buybacks | ||
| Buyback yield | 7.3% (better) | 2.1% |
| Shareholder yield | 7.3% (better) | 2.1% |
| Ownership | ||
| Held by institutions | 107% | 78.6% |
| Held by insiders | 11.4% | 23.8% |
| Insider net buying, 12 months | −$6.9M (better) | −$7.5M |
| Short interest, % of float | 15.0% | 1.9% |
Go deeper
- FIVN stock overview
- FIVN income statement
- FIVN valuation and score
- IBEX stock overview
- IBEX income statement
- IBEX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.